Assessment reveals adipokine relationships with inflammation in menopausal women with multiple sclerosis, indicating hormone therapy may impact disease management.
Key Points
Adipokine imbalance correlates with inflammation markers in multiple sclerosis.
The adipokine profile shows a significant relationship with body mass index and tumour necrosis factor.
Assessment involved menopausal women with MS and healthy controls over one year of hormone therapy.
Findings support further investigation into multibiomarker profiling for MS in menopausal women.